Jamalzei Behzad, Fallah Soudabeh, Kashanian Maryam, Seifi Morteza
Biochemistry Department of Tehran University of Medical Sciences, Hemmat High Way, Tehran, Iran.
Clin Lab. 2013;59(5-6):563-70. doi: 10.7754/clin.lab.2012.120304.
Apolipoprotein E (ApoE) polymorphism plays a significant role in the development of several diseases, but its role in the preeclampsia disease incidence is not clear. Therefore, the purpose of this study was to investigate the susceptibility of some pregnant women to preeclampsia.
In a comparative cross-sectional study, the ApoE polymorphism genotypes were investigated in 100 patients with preeclampcia and 100 normal pregnant, using the polymerase chain reactions (PCR) analysis. Serum lipids and lipoproteins concentrations were also evaluated using the commercially available kits.
The difference in distribution of the epsilon2/epsilon2, epsilon2/epsilon3, epsilon2/epsilon4, epsilon3/epsilon3, epsilon3/epsilon4 and epsilon4/epsilon4 genotypes between patient subjects and controls was not significantly (p = 0.266). The data obtained for Apo epsilon4, epsilon2 and epsilon3 alleles in the patient group was not different significantly from those obtained for the control group (p = 0.220). The VLDL and TG levels of the patient group were higher significantly than controls (p < 0.01, p < 0.01 respectively). The data obtained for HDL concentration (52.2 +/- 16.1 g/dL) of the patient group was not different significantly from controls (49.4 +/- 12.5 g/dL). The difference between LDL concentration of patients with preeclampsia and controls was not significant. The cholesterol concentration of control subjects was not different significantly from patient subjects.
The observed profiles of ApoE alleles and genotypes frequencies suggest that Apo E polymorphism does not play a major role in the development of preeclampsia. Nonetheless, the abnormal lipid profiles that we found in patients with preeclampsia may have a genetic explanation and/or contribution.
载脂蛋白E(ApoE)多态性在多种疾病的发生发展中起重要作用,但其在子痫前期疾病发病率中的作用尚不清楚。因此,本研究旨在调查部分孕妇患子痫前期的易感性。
在一项比较性横断面研究中,采用聚合酶链反应(PCR)分析,对100例子痫前期患者和100例正常孕妇的ApoE多态性基因型进行了研究。还使用市售试剂盒评估了血清脂质和脂蛋白浓度。
患者组和对照组之间的ε2/ε2、ε2/ε3、ε2/ε4、ε3/ε3、ε3/ε4和ε4/ε4基因型分布差异无统计学意义(p = 0.266)。患者组中Apo ε4、ε2和ε3等位基因的数据与对照组的数据差异无统计学意义(p = 0.220)。患者组的极低密度脂蛋白(VLDL)和甘油三酯(TG)水平显著高于对照组(分别为p < 0.01,p < 0.01)。患者组高密度脂蛋白(HDL)浓度(52.2±16.1 g/dL)的数据与对照组(49.4±12.5 g/dL)差异无统计学意义。子痫前期患者与对照组的低密度脂蛋白(LDL)浓度差异无统计学意义。对照组的胆固醇浓度与患者组差异无统计学意义。
观察到的ApoE等位基因和基因型频率表明,ApoE多态性在子痫前期的发生发展中不起主要作用。尽管如此,我们在子痫前期患者中发现的异常脂质谱可能有遗传解释和/或贡献。